Genitourinary Radiology: Page 6

Telix posts 2023 half-year report

By AuntMinnie.com staff writers

Telix Pharmaceuticals reported a spike in revenue for the first half of 2023, citing strong sales of its Illucix kit for preparing gallium-68 gozetotide injections for PET prostate cancer imaging.

August 22, 2023

AI developed for SPECT kidney imaging in children

By Will Morton

An AI model based on SPECT images has the potential to help nuclear medicine physicians identify kidney defects in children, according to a research group in Taiwan.

August 16, 2023

Clarity advances dose escalation for cohort in SECuRE trial

By AuntMinnie.com staff writers

Radiopharmaceutical developer Clarity Pharmaceuticals is highlighting the completion of the second cohort, as well as the advancement to the third cohort in the dose escalation phase of its phase I/II theranostic trial, SECuRE.

August 9, 2023

MRI fusion-targeted plus systematic biopsy identifies prostate cancer

By Kate Madden Yee

The combination of ultrasound and MRI fusion-targeted biopsies with systematic biopsies is more effective for identifying suspicious lesions than systematic biopsies alone, a study published July 25 in Radiology has found.

July 25, 2023

NCCN adds Blue Earth's Posluma to its oncology guidelines

By AuntMinnie.com staff writers

The National Comprehensive Cancer Network (NCCN) has added Blue Earth Diagnostics' Posluma (Flotufolastat F-18) PET radiotracer to its oncology guidelines for imaging prostate cancer.

July 24, 2023

Pluvicto patient response criteria validated

By Will Morton

Doctors now have a reliable approach for determining whether prostate cancer patients are responding to prostate cancer treatment with Pluvicto, according to research published July 11 in Radiology.

July 11, 2023

Presurgical MRI predicts cancer recurrence after prostatectomy

By Kate Madden Yee

Preprostatectomy, MRI-based staging features perform comparably to postsurgical pathologic staging features for predicting whether prostate cancer will recur, according to a study published July 5 in the American Journal of Roentgenology.

July 5, 2023

AI developed for staging patients with prostate cancer

By Will Morton

An AI model based on prostate-specific membrane antigen-PET/CT imaging performs well in staging prostate cancer patients for surgery, according to a talk at the Society for Nuclear Medicine and Molecular Imaging meeting in Chicago.

July 2, 2023

SNMMI: Tailored prostate cancer treatment improves outcomes

By Kate Madden Yee

Monitoring response during lutetium-177 prostate-specific membrane antigen radioligand therapy improves outcomes, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Chicago.

June 27, 2023

Blue Earth highlights Posluma study results

By AuntMinnie.com staff writers

Blue Earth Diagnostics, a Bracco company, is highlighting results from a study that explored the impact of urinary activity on the interpretation of its flotufolastat F-18 injection (Posluma).

June 26, 2023

SNMMI: PET tracer describes clear cell renal cancer

By Amerigo Allegretto

A new PET tracer can accurately detect and differentiate a certain type of kidney cancer from other kidney tumor types, according to research presented June 26 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 26, 2023

Avenda spotlights AI prostate cancer study

By AuntMinnie.com staff writers

AI software developer Avenda Health is highlighting clinical results that suggest its Unfold AI imaging software is effective in prostate cancer patients.

June 13, 2023

Previous Page

Page 6 of 93

Next Page